IMR Press / EJGO / Volume 39 / Issue 5 / DOI: 10.12892/ejgo4002.2018

European Journal of Gynaecological Oncology (EJGO) is published by IMR Press from Volume 40 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Open Access Case Report
Metastatic squamous cell carcinoma of the cervix: complete response under maintenance strategy with bevacizumab
Show Less
1 Oncology Unit Gard Cancer Institute, Nîmes, France
Eur. J. Gynaecol. Oncol. 2018, 39(5), 828–829; https://doi.org/10.12892/ejgo4002.2018
Published: 10 October 2018
Abstract

Cervical carcinoma is a common cancer. Metastatic disease will develop in 15% to 61% percent women, usually within the first two years of completing treatment. We present a case of a 56-year-old patient with a Stage IIIB carcinoma of the cervix, treated with chemoradiation, brachytherapy and surgery. Nine months after completion of primary treatment, she presented with latero-aortic metastatic adenomegalies. She received six courses of chemotherapy carboplatin+paclitaxel+bevacizumab, followed by maintenance by bevacizumab. After ten months of bevacizumab and three years after the diagnosis, the patient is alive, without further evidence of disease.
Keywords
Cervical cancer
Cervix
Maintenance strategy
Bevacizumab
Share
Back to top